Best Online Peptide Therapy Clinics (2026): 12 Telehealth Providers Compared

Key takeaways

• We checked twelve US telehealth providers on their own websites on October 9, 2026 and recorded what they list, what they charge, which states they serve, how the clinician visit works, whether they name a pharmacy, whether they require labs and whether FDA has written to them. No ratings, no superlatives, no paid placements.
• The published prices cluster tightly: sermorelin $153 to $233 a month, NAD+ injections $149 to $189, glutathione $149 to $179, usually with a cheaper first month. The real differences are in what is included and what is disclosed.
• Only two of the twelve name the pharmacy that fills their prescriptions on the website (PepScribe and System Labs). Three list bloodwork as a prerequisite for any prescription (Hone, Ways2Well, Defy Medical); two say labs are not required for peptides (PepScribe, Ivy Rx); the rest leave it to the clinician or do not say.
• Three providers list compounds on their menus that no pharmacy may legally compound in October 2026 (BPC-157, TB-500, MOTS-c and others), and a fourth names AOD-9604 as an example of what a plan may include. Such products cannot be pharmacy-compounded, whatever the consultation looks like; our legal tracker explains the status of each.
• The two largest platforms, Hims and Ro, listed GLP-1 drugs and no other peptides on the day we checked. Hims has announced sermorelin, glutathione and NAD+ for later in 2026.

Disclosure. The Peptide Doctrine is an independent editorial project. It currently has no sponsor and runs no advertising: we accept no payment for reviews, rankings or placements, we run no affiliate links, and we do not sell or link to "research-use" peptide vendors. Content is educational and is not medical advice.

How we compared them

We started from a list of nineteen names that come up in searches for online peptide therapy, visited each one's website on October 9, 2026, and kept the twelve that are telehealth prescribers offering at least one peptide drug to patients in more than one state. For each we recorded, from the provider's own pages only:

• Compounds listed, by name, and whether each can be legally compounded as of October 2026 according to our legal tracker. Where a provider lists a compound that no pharmacy may make (BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, AOD-9604, epitalon, KPV, dihexa, injectable GHK-Cu), we say so plainly: such a product cannot be pharmacy-compounded, so it is either not actually available or not coming from a pharmacy (FDA 503A bulks list).
• Pricing model and sample prices, quoted as published, with what is and is not included.
• States served, as stated.
• Clinician model: synchronous (live video or phone) or asynchronous (questionnaire reviewed later), and who the prescribers are.
• Pharmacy: whether a pharmacy or 503B outsourcing facility is named on the site.
• Labs: whether bloodwork is required before a prescription.
• FDA warning letters: whether the company appears in the recipient lists we could find for the telehealth letters of September 2025, February 20 / March 3, 2026 and June 8 / June 16, 2026 (FDA, March 2026; Telehealth.org, June 2026; TheRxIndex tracker). FDA has not published one consolidated list, so "not named" means not named in those sources.

We did not rank. The same criteria apply to every provider, a fact we could not verify is marked as not stated, and no provider paid for placement or saw this page before publication. Seven names from the starting list were excluded; the reasons are at the end.

Comparison at a glance

Prices and lists are as published on October 9, 2026 and will change; treat them as a snapshot, not a quote.

The twelve providers

Hone Health

Hone is a telehealth platform whose medical care comes from independently owned practices of licensed physicians using its software, a structure its site spells out. The process is fixed: buy a $65 biomarker test, draw at a partner lab or at home, then a telehealth consult in which a Hone-affiliated physician reviews the labs and history and writes a plan. Two memberships: Basic at $25 a month (lab testing every six months, the option to buy physician consults, member pricing) and Premium at $155 a month (regular labs, consults and full access to medications). Its longevity pages list NAD+, glutathione, B12, low-dose naltrexone, metformin and prescription omega-3; the men's and women's menus add testosterone, GLP-1 weight loss, thyroid, ED, hair and menopause treatment. We could not find a sermorelin page (the obvious URL returns a not-found page), although third-party sites quote a Hone sermorelin price; we report only what Hone shows. Medication prices are not published outside the member experience, the pharmacy is not named, and the state list is not on the pages we loaded. The strongest point in Hone's favor on our criteria is that labs come before everything.

Hims

On October 9, 2026 Hims' weight-loss pages listed a GLP-1 lineup that includes Wegovy, Zepbound, Foundayo, Ozempic and Mounjaro, with medication priced from $149 to $1,899 a month on top of a Weight Loss Membership ($39 for the first month, then $149 a month, billed separately and not FSA or HSA eligible). The site says the program is not available in all 50 states but does not publish the list. No sermorelin, NAD+ or glutathione appeared anywhere we looked. That is about to change: on its August 10, 2026 earnings call the company said it would launch a wellness and peptide category with sermorelin, glutathione and NAD+ by the end of 2026, with BPC-157 in stability testing pending FDA rulemaking (The Peptide Catalog, August 2026); as of our check, no such product was on sale. Hims is also the one provider here with FDA letters on file: two dated September 9, 2025, to its Hims and Hers brands, over website claims about compounded semaglutide (FDA, Hims; FDA, Hers). It does not appear in the 2026 recipient lists we found. Pharmacy and lab requirements are not stated on the pages we loaded.

Ro

Ro's weight-loss program leads with "FDA-approved options" and brand GLP-1s, with an insurance concierge that checks coverage and handles prior authorization, and cash-pay shipping for the rest. Its site also sells compounded erectile-dysfunction products (Sparks and Daily Rise gummies), which it labels as compounded and not FDA-approved. We found no sermorelin, NAD+, glutathione or other peptide on the home or weight-loss pages. Prices, the state list and the pharmacy were not on the pages we loaded, so we do not report them; Ro's intake is 100% online with licensed providers, and it is not named in any warning-letter list we reviewed. For a reader whose goal is weight, Ro is a GLP-1 provider; for any other peptide, it is not currently an option.

Henry Meds

Henry Meds is a GLP-1-first telehealth service: compounded semaglutide, tirzepatide tablets, liraglutide, microdose and oral options, plus phentermine, testosterone, women's hormone therapy and ED. No NAD+, sermorelin or other peptide appears on its site. The model is one monthly payment covering the provider visit, medication, supplies, shipping and ongoing care, with monthly or longer plans; the FAQ says prices appear during checkout, and the public pages we loaded did not list a dollar figure. Visits are by video, or in some states by a provider review without video, with portal messaging after. The pharmacy is not named; the FAQ says medication is made in a state-licensed 503A pharmacy or a 503B outsourcing facility, and that California orders take longer because of compound testing requirements. Labs are ordered if necessary. Henry is not named in the warning-letter lists we found. The thing to check before enrolling is the multi-month plan term: the FAQ says you may have to pay out the balance if you cancel early without a medical reason. Our Henry Meds review has its full price list and terms.

Ways2Well

Ways2Well is a labs-first longevity practice with telehealth-only consults and in-person services in Austin and Houston. Its peptide page describes categories (weight loss, recovery, muscle growth, anti-aging, cognition, sexual health) without naming a single compound, which makes it the one provider here whose offer we could not characterize by molecule. The peptide consult is $99 for 20 minutes, with peptides purchased separately if prescribed, and the site says labs and biomarker testing are required and that a provider reviews labs before anything is prescribed. Care Plans run from a complimentary 20-minute phone call to Clarity ($499 one-time: one blood panel and a 40-minute video consult) and Core ($125 a month or $1,499 a year: three panels and four consults), with draws at Quest. Its state information is inconsistent across pages: 46 states on the home page with New York, New Jersey, Rhode Island and Missouri on a waitlist; 43 states plus DC on the peptide page, with California, Ohio and Nevada limited to weight-loss peptides; 44 states plus DC in the FAQ. The pharmacy is not named ("compounded in regulated U.S. facilities"). HSA and FSA cards are accepted; insurance is not. Not named in the warning-letter lists we found.

PepScribe

PepScribe, which announced its launch in July 2026, is a Johnston, Iowa telehealth technology platform whose clinical services come from Ola Digital Health. It is the most explicit provider here about its supply chain: every plan is compounded by a licensed 503A pharmacy, not a 503B facility, and the pharmacy partners page names MediVera Compounding Pharmacy in Troy, Michigan. The catalog covers sermorelin, NAD+ (injection and nasal spray), glutathione, PT-141, GHK-Cu cream, compounded semaglutide and tirzepatide (injection and oral), low-dose naltrexone and B12, plus testosterone, enclomiphene, hormone therapy, thyroid and ED drugs. Everything on the list is an approved drug or legally compoundable; the GHK-Cu cream relies on FDA's interim policy for non-injectable GHK-Cu, which FDA returned to Category 1 in May 2026 (see our GHK-Cu profile). Prices are published per compound: sermorelin $189 a month month-to-month or $153 on a three-month plan with a $99 first month; NAD+ $189 or $150 on three months; plans start from $79 a month with medication and shipping included and no membership fee. Intake is a free asynchronous questionnaire reviewed by a US-licensed clinician, typically within 24 hours, with messaging after; nine jurisdictions (Arkansas, Kansas, Mississippi, Missouri, New Mexico, North Dakota, Oregon, West Virginia and DC) require a brief live visit, which is built into the flow, and availability in California and DC varies by treatment. Labs are not required for peptide plans, which is defensible for NAD+ and less so for sermorelin, where a baseline IGF-1 is the only objective reason to prescribe (Corpas 1992). Not named in the warning-letter lists we found.

System Labs

System (System Laboratories, Inc.) sells a short, fixed menu with the clearest price list in this comparison: NAD+ injection $149 a month ($89 for the first month), NAD+ nasal spray $119 ($69 first), glutathione $149 ($79 first), MIC+B12 $89, sermorelin injection $219 ($109 first; described as a monthly supply of 9 mg) and an oral dissolving sermorelin tablet at $159 ($79 first). Everything on the menu can be legally compounded. The process is a two-minute intake, review by a licensed provider who reaches out by chat, and a telemedicine consultation with a provider licensed in your state; the site says it is available in all 50 states subject to state telehealth and pharmacy rules. The FAQ names the dispensing pharmacy, The Pharmacy Hub in Miami, without stating whether it operates under 503A or 503B, and says some therapies require baseline labs. It is cash-pay, cancel any time, and carries the usual statement that its peptide therapies are not FDA-approved. Not named in the warning-letter lists we found. The one question we would put to System is what the 9 mg monthly supply of sermorelin means per night, since the published trial doses were far higher.

Midi Health

Midi is a women's virtual clinic built around perimenopause and menopause care, in all 50 states, with board-certified nurse practitioners and physicians, and it is the only provider here that bills visits to insurance (in-network with most major plans; self-pay $250 for a first visit and $150 for follow-ups; Medicare and Medicaid not accepted). Its store lists compounded sermorelin at $179 starting per month, shipped from a compounding pharmacy it does not name, and its sermorelin monograph lists pregnancy, nursing, cancer and thyroid conditions as precautions. GLP-1 prescriptions and hormone therapy are the core products; we found no NAD+ or glutathione. Labs appear in its care plans, though the sermorelin page does not state a lab requirement. Not named in the warning-letter lists we found. Midi's relevance here is narrow and real: a woman whose first question is menopause and whose second is a peptide gets both from one chart, with the clinician trained in the first.

Defy Medical

Defy is a Tampa clinic that has offered telemedicine for more than a decade, with no subscriptions or contracts: you pay for consults, labs and medication as you go. Intake starts with a patient advocate, new-patient requirements include blood testing, a recent physical and a history, and the consult is virtual. Its peptide page is the reason it appears in our flags column. The "Peptide Treatment Options" listed are BPC-157, TB-500, epithalon, KPV, MOTS-c and sermorelin, with a CJC plus ipamorelin image and a tesamorelin article alongside. Of those, only sermorelin can be compounded in October 2026, and tesamorelin is lawful only as the brand Egrifta, because as a biological product it cannot be compounded; BPC-157, TB-500, epithalon, KPV and MOTS-c were recommended by FDA's advisory committee in July 2026 but are not on the 503A list and may not be compounded until FDA completes rulemaking (HPM 2026a), and CJC-1295 and ipamorelin were voted down in 2024 (FDA PCAC 2024). The page does not say whether these are available now, pending or aspirational, prices are not published, the pharmacy is not named and the state list is not on the pages we loaded. Not named in the warning-letter lists we found. A reader should ask Defy directly which of the listed peptides it will actually prescribe today, and from which pharmacy.

Ivy Rx

Ivy Rx (Ivy RX PLLC, Miami) runs a fully asynchronous model: a five-minute online questionnaire, same-day review by a licensed provider, and shipping from an unnamed partner pharmacy that the site describes as FDA-registered and compliant with 503B and USP 797 standards. Published prices: sermorelin $175 on the peptides page and "from $179" on the product page, NAD+ $179, glutathione $179, MIC+B12 $179, GLP-1 $77 and GLP-1 microdose $69, with the billing period not stated for any of them. It also lists Ozempic, Mounjaro and metformin. The sermorelin product page says labwork is not required, while the same page's FAQ defines candidacy by a sub-optimal IGF-1 on lab testing, a contradiction a buyer should notice. The flag is BPC-157: Ivy sells "BPC-157 Capsules" at $129 for 60 capsules of 500 mcg, pictured as a dietary supplement while the text says BPC-157 may be compounded. Neither description works. No pharmacy may compound BPC-157 in October 2026, and a drug substance with no history of use in food is not a lawful dietary ingredient. States served are not listed. Not named in the warning-letter lists we found.

RegenMD Wellness

RegenMD is an Atlanta regenerative clinic that offers consultations virtually where permitted and ships nationwide, with a two-step intake: a call with a wellness consultant, then an evaluation by a licensed provider, virtual or in person, that reviews labs and history before anything is prescribed. Its memberships carry six-month commitments: a Peptides tier at $79 a month for 10% off peptide programs, Wellness at $99 (semaglutide $299 a month, tirzepatide $349, one free lab workup a year), a Slim tier (semaglutide $199, tirzepatide $349), Platinum at $199 (20% off peptides, two lab workups) and testosterone or hormone tiers at $199, the TRT tier in Georgia only. Individual peptide prices are not published, refills ship for $25, and medications are not auto-shipped. The catalog is the longest in this comparison, and most of its flags come from it. The injectable list includes sermorelin, NAD+, glutathione and compounded GLP-1s, which can be compounded, next to BPC-157, MOTS-c, AOD-9604, injectable GHK-Cu and IGF-1 and a dozen branded blends ("Fat Burner," "Recovery," "Immunity Shield") whose contents are not stated; the capsule list adds BPC-157, dihexa, MK-677, SLU-PP-332 and tesofensine. BPC-157, MOTS-c, AOD-9604, dihexa and injectable GHK-Cu cannot be pharmacy-compounded in October 2026, and MK-677, SLU-PP-332 and tesofensine have never been approved as drugs in the United States. The pharmacy is not named. Not named in the warning-letter lists we found. The question to ask RegenMD is what is in each blend and on what legal basis a pharmacy prepares it.

Premier Hormone Health and Wellness

Premier is a hormone-first virtual practice (its FAQ says all visits are virtual, across many US states; the footer says serving all states) that publishes sermorelin at $233 a month for men and $199 for women, prescribed by licensed physicians and dispensed from unnamed FDA-registered US pharmacies. Testosterone is $149 a month or $99 a month on an annual plan after a $99 fee, with labs separate at $149 per standard panel every six months through LabCorp, prior bloodwork accepted if under 12 months old, and patients must be 25 or older. It does not bill insurance. The peptide page is written around process rather than a catalog, and the one compound it names as an example of what a plan might include is AOD-9604, which FDA's advisory committee reviewed in December 2024 and which cannot be compounded (FDA PCAC 2024). Labs are required for some therapies and the TRT pathway follows the two-morning-draw standard. Not named in the warning-letter lists we found. Premier is the most transparent provider here on hormone pricing and among the least on which peptides it will actually prescribe.

What the comparison shows

Disclosure is the dividing line, not price. Sermorelin costs $153 to $233 a month wherever you buy it, because the ingredient is cheap and the clinician and pharmacy costs dominate. What separates the providers is whether they tell you where the vial comes from: two name their pharmacy, ten do not. Under federal law a compounded drug is not FDA-approved and its quality depends on the pharmacy that made it (FDA compounding Q&A), so an unnamed pharmacy is an unanswered question about the only part of the product that matters.

Asynchronous is common. Four of the twelve prescribe from a questionnaire with messaging after (Hims, Ro, PepScribe, Ivy Rx), two more offer a review without a live visit depending on the state (Henry Meds, System Labs), and only where state law insists do they schedule one. That is legal for non-controlled drugs and fine for a B12 shot. For a GLP-1 or a growth hormone secretagogue it means the evaluation is only as good as the form, which is why the labs question matters so much.

Labs are optional at the cheap end. Two providers say labs are not required for peptides. Our complete guide explains which compounds can be prescribed responsibly without them (NAD+, glutathione) and which cannot (sermorelin without an IGF-1, a GLP-1 without an A1c).

Non-compoundable peptides are still on menus. Three providers list compounds that no pharmacy may make, and a fourth names one as an example of what it might prescribe. Whether those listings are aspirational, pending the FDA rulemaking everyone is waiting for, or describe a product sourced outside the pharmacy system, the website does not say, and a buyer cannot tell. The safe assumption is the one FDA's reviewers made in July 2026: no adequate human data, no legal pharmacy supply (HPM 2026a).

Vials need counseling. Several providers ship compounded GLP-1s in vials with syringes. A poison-center series documented ten-fold overdoses from patients dosing in units or milliliters instead of milligrams, with symptoms lasting days (Lambson 2023). Ask how the dose is written on the label and use our units guide before the first injection.

Also checked, and why they are not in the table

• Marek Health: a labs-first telehealth coaching platform available in all 50 states, with mandatory diagnostic panels (a $450 minimum on the performance program, repeat labs at 6 to 12 weeks and every six months), health coaches plus partnered licensed providers, and fulfillment through 503A and 503B compounding pharmacies it does not name. Its public pages name no peptides, so we could not characterize an offer; its site also blocks visitors outside the United States. Not named in the warning-letter lists we found.
• Dr. Jones DC Wellness Institute: a Denver and Colorado Springs practice led by a chiropractor, with nurse practitioners on staff and "support plans online" for GLP-1s and peptides that it says serve all US states. Its peptide pages cover BPC-157, TB-500, CJC-1295 with ipamorelin, AOD-9604, dihexa, KPV, MK-677, selank, sermorelin and tesamorelin, most of which cannot be compounded, and the pages we loaded did not state prices or which licensed prescriber writes prescriptions in which states. We excluded it until those two facts are published.
• Relive Health: a clinic network and franchise offering a "peptide protocol" among in-person services; its site does not describe telehealth prescribing and names no compounds.
• Perfect B: a Doral, Florida clinic whose peptide page lists CJC and ipamorelin, BPC-157 with TB-500, tesamorelin, epithalon, MOTS-c, GHK-Cu and semax at $445 per cycle for one peptide; injection training happens at the first in-person visit and telehealth is not mentioned. Most of that list cannot be compounded.
• Limitless Male: 17 men's clinics in nine states that describe themselves as "a real men's health clinic, not an online service"; sermorelin, NAD+ and PT-141 are offered in person.
• Fountain: an online testosterone clinic (cream, $199 a month, 20 states, video visit after labs) that lists no peptides.
• Recovery Project: we could not find a provider website under that name.

How to use this page

1. Decide the compound first, using the evidence by goal and the legal tracker. If it cannot be compounded, no provider on this page can legally supply it, whatever the menu says.
2. Price three months, not one: the first-month discounts here are $50 to $110, and the memberships at Hone, Hims, RegenMD and Ways2Well sit on top of the medication.
3. Ask the two questions ten providers do not answer on their sites: which pharmacy, and what labs.
4. Check the state list on the day you enroll; two of the twelve publish lists that disagree with themselves.
5. Treat any provider's FDA letter history as a reason to read their current claims closely, and search FDA's warning-letter database for the name before you pay. Our cost guide covers what the quotes should include.

Frequently asked questions

+−Can telehealth prescribe peptides?

Yes, for the peptides a licensed pharmacy may legally compound or a manufacturer makes: sermorelin, tesamorelin (as the brand Egrifta only), bremelanotide (PT-141), glutathione, NAD+ and, within limits, semaglutide and tirzepatide. The prescriber must be licensed in the state you are in during the visit. No telehealth provider can legally prescribe BPC-157, TB-500, CJC-1295, ipamorelin or MOTS-c in October 2026, because no pharmacy may compound them.

+−Can you get prescribed peptides online?

Yes. Every provider in this comparison takes an online intake, has a licensed clinician review it (by video in some cases, by questionnaire and messaging in others) and ships from a compounding pharmacy if a prescription is issued. The differences that matter are which compounds they list, whether they name the pharmacy, whether they order labs, and what the second month costs.

+−Can I get a BPC-157 prescription online?

Not a prescription any pharmacy can legally fill. As of October 2026 BPC-157 is not FDA-approved and is not on FDA's list of substances that 503A pharmacies may use, so a licensed pharmacy may not compound it. Three providers in this comparison list BPC-157 anyway, one of them as a capsule it also calls a dietary supplement; we flag them and explain why in the provider sections.

+−What is the most trustworthy peptide company?

We do not rank, because trust is not a single number. The verifiable signals are: the pharmacy is named on the website and on the label; labs are ordered when the compound calls for them; the compounds listed can all be legally compounded; the price for month two is published; and the company does not appear in FDA's warning-letter database. In this comparison PepScribe and System Labs name their pharmacies, Hone, Ways2Well and Defy Medical require labs before anything is prescribed, and Defy Medical, RegenMD and Ivy Rx list compounds no pharmacy may make.

+−What is a peptide clinic?

A medical practice, in person or online, that prescribes peptide drugs for goals such as weight, body composition, sexual function or energy. Online, it is usually three parties: a technology brand, an independent medical group whose clinicians prescribe, and a compounding pharmacy that fills the prescription. Ask all three to be named.

+−How much do peptide treatments cost online?

On October 9, 2026 the published prices in this comparison ran $153 to $233 a month for sermorelin, $149 to $189 for NAD+ injections and $149 to $179 for glutathione, with first-month discounts common. GLP-1 options ran $77 to $349 a month for compounded products depending on the provider and dose, and up to $1,899 a month for brand products at Hims. Memberships, consults and labs add $25 to $499 up front. Our cost guide covers the full market.

+−Can peptides be shipped to my home?

Yes. Compounded peptides ship cold from the pharmacy to your address, usually within a week of approval. Some states restrict which compounded products may be shipped in, which is why providers publish state lists and why a compound can be 'unavailable in your state.'

+−Who qualifies for peptide therapy online?

Adults with a goal that a prescribable compound has evidence for and no contraindication: for GLP-1s, no personal or family history of medullary thyroid cancer; for sermorelin or tesamorelin, no active cancer and ideally a documented low IGF-1; for bremelanotide, controlled blood pressure. A provider that approves everyone in minutes without a history is not qualifying you.

Sources

1. RegulatoryFDA. FDA warns 30 telehealth companies against illegal marketing of compounded GLP-1s (letters dated February 20, 2026). Press announcement, March 3, 2026. (2026)
2. NewsTelehealth.org. FDA sends new round of warning letters (25 companies, letters dated June 8, 2026, posted June 16) over compounded GLP-1 marketing claims. June 2026. (2026)
3. NewsFrier Levitt. From crackdown to collaboration: FDA warning letters and the Hims-Novo Nordisk deal signal a new era for compounded GLP-1 drugs. March 9, 2026. (2026)
4. RegulatoryFDA. Warning letter to Hims & Hers Health, Inc. dba Hims (compounded semaglutide marketing). September 9, 2025. (2025)
5. RegulatoryFDA. Warning letter to Hims & Hers Health, Inc. dba Hers (compounded semaglutide marketing). September 9, 2025. (2025)
6. SourceTheRxIndex. Compounded GLP-1 enforcement tracker: FDA warning letters and safety data 2026 (recipients coded by letter date). (2026)
7. NewsThe Peptide Catalog. Hims & Hers peptide launch: sermorelin, glutathione and NAD+ by end of 2026, BPC-157 pending FDA rulemaking (report on the August 10, 2026 earnings call). August 20, 2026. (2026)
8. RegulatoryFDA. Bulk drug substances used in compounding under section 503A of the FD&C Act (the 503A bulks list and interim categories).
9. RegulatoryFDA. Compounding and the FDA: questions and answers (503A pharmacies versus 503B outsourcing facilities; compounded drugs are not FDA-approved).
10. NewsPalmer KL, Snow CD, Bass M. PCAC approves four bulk drug substances for the 503A list (BPC-157, KPV, TB-500, MOTS-c). FDA Law Blog, Hyman Phelps & McNamara, July 24, 2026. (2026)
11. RegulatoryFDA. 2024 meeting materials, Pharmacy Compounding Advisory Committee (October 29, 2024: ipamorelin; December 4, 2024: CJC-1295, AOD-9604, thymosin alpha-1). (2024)
12. StudyLambson JE, Flegal SC, Johnson AR. Administration errors of compounded semaglutide reported to a poison control center: case series. J Am Pharm Assoc 2023;63:1643-5. (2023)
13. StudyCorpas E et al. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and IGF-I levels in old men. J Clin Endocrinol Metab 1992;75:530-5. (1992)